HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
Previous close
$3.74
Day range
$3.55 - $3.69
Year range
$2.30 - $30.66
Market cap
16.08M USD
Avg Volume
37.34K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 304.00K | -94.36% |
Operating expense | 2.54M | -75.31% |
Net income | -3.94M | -914.05% |
Net profit margin | -1.30K | -14,548.72% |
Earnings per share | 0.00 | — |
EBITDA | -2.13M | 59.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.16M | -29.71% |
Total assets | 43.27M | -33.02% |
Total liabilities | 23.20M | -54.17% |
Total equity | 20.07M | — |
Shares outstanding | 2.56B | — |
Price to book | 374.00 | — |
Return on assets | -13.27% | — |
Return on capital | -17.12% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.94M | -914.05% |
Cash from operations | -177.00K | 98.44% |
Cash from investing | -3.70M | 57.15% |
Cash from financing | 1.60M | -93.29% |
Net change in cash | -1.85M | -150.84% |
Free cash flow | 2.11M | 136.75% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
28
